A CRISPR-HITI strategy approach to improve CHO cell viability by modifying the 3'UTR of Caspase 8 Associated Protein 2
2025

Improving CHO Cell Viability with CRISPR-HITI

publication Evidence: moderate

Author Information

Author(s): Sorourian Soofia, Behzad-Behbahani Abbas, Forouzanfar Mohsen, Jafarinia Mojtaba, Safari Fatemeh

Primary Institution: Shiraz University of Medical Sciences

Hypothesis

Can modifying the 3'UTR of the CASP8AP2 gene improve CHO cell viability?

Conclusion

The deletion of the CASP8AP2 gene enhances CHO cell viability and resistance to apoptosis without affecting cell proliferation.

Supporting Evidence

  • The study confirmed the deletion of the CASP8AP2 gene through PCR and sequencing.
  • CHO-KO cells showed higher resistance to apoptosis compared to native CHO-K1 cells.
  • The IC50 for sodium butyrate was higher in CASP8AP2 knockout cells than in native cells.
  • Cell proliferation was not significantly affected by the deletion of the CASP8AP2 gene.

Takeaway

Scientists changed a part of a gene in CHO cells to help them live longer and resist dying when treated with a certain chemical.

Methodology

The study used CRISPR-HITI to modify the CASP8AP2 gene in CHO cells and assessed cell proliferation, viability, and apoptosis through various assays.

Limitations

Further research is needed to elucidate the molecular mechanisms and develop therapeutic strategies based on this approach.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.22099/mbrc.2024.50513.2000

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication